W. Scott Harkonen, MD
Saturday, June 28th, 2008W. Scott Harkonen, M.D., is President and Chief Executive Officer of CoMentis, a pharmaceutical company engaged in the discovery and development of small-molecule drugs to treat Alzheimer’s disease, age-related macular degeneration (AMD) and cognitive disorders.